Bitcoin

Bitcoin
Bitcoin

Broadcom stock is in a local bear market: will it retest its record high?

Broadcom stock price rose by 5% on Wednesday after extending its relationship with Apple. AVGO rose to $395, a 10% increase from its lowest level this month. It remains in a local bear market after falling by 20% from its highest point this year. So, will it rebound and retest its all-time high? Broadcom expands

Read More
Bitcoin

Salesforce stock falls after KeyBanc downgrade on AI growth concerns

Salesforce Inc. (CRM) shares fell 2.5% on Thursday after KeyBanc downgraded the software company, citing concerns that its Agentforce artificial intelligence platform may take longer than expected to become a meaningful growth driver. The downgrade came despite Salesforce’s strong position in enterprise software and follows the company’s better-than-expected fiscal first-quarter results reported in late May.

Read More
Bitcoin

Is the 3.2% yielding SCHD ETF a buy as one-year Treasury yields hit 4.06%?

The Schwab US Dividend Equity ETF (SCHD) has moved sideways in the past few days. It has remained inside the key support and resistance levels of $31.60 and $32.90 since May. Despite the consolidation, SCHD is having a strong year, with inflows rising by over $13 billion and its assets nearing the $100 billion mark.

Read More
Bitcoin

Fiserv stock rises 6% as top US banks reportedly consider buying its card network

Shares of Fiserv climbed more than 6% in premarket trading on Tuesday after a report said several of the largest US banks had explored acquiring one of the fintech company’s debit-card networks, highlighting the growing strategic importance of payments infrastructure as banks compete with fintech firms and crypto players. According to The Wall Street Journal,

Read More
Bitcoin

Top 5 reasons why S&P 500 Index and VOO ETF have more upside to go this year

The S&P 500 Index and the VOO ETF have largely stagnated over the past two months as some of their biggest constituents, including Nvidia and Meta Platforms, have pulled back. The index was trading at 7,537, up 20% from its lowest level this year, and several key technical and fundamental factors suggest it has further

Read More
Bitcoin

FTSE 100 rises as Shell boosts energy stocks despite mining weakness

The UK’s FTSE 100 index edged higher on Tuesday as gains in energy stocks, led by Shell, offset weakness in precious metals miners. Rising oil prices and strength in consumer-focused shares also supported the benchmark index, while the midcap FTSE 250 traded lower. Energy stocks lead market gains The blue-chip FTSE 100 index rose 0.2%

Read More
Bitcoin

Rivian stock has flagged an inverted H&S pattern: will the rally continue?

Rivian stock is doing well this month and beating its top rivals like Lucid and Tesla, helped by its strong vehicle delivery numbers. RIVN soared to $20.15 on Monday, its highest level since January 8. This rally may continue ahead of its earnings, which are coming out on July 30th.  Rivian stock may have more

Read More
Bitcoin

Cheap, capable, and controversial: why US companies cannot resist Chinese AI models

Artificial intelligence adoption accelerated sharply across enterprises in 2026, but soaring usage costs are prompting many businesses to rethink their technology choices. This has driven growing interest in Chinese-developed AI models that offer comparable capabilities at a fraction of the price. As companies expand AI deployments across software development, customer service and workflow automation, many

Read More
Bitcoin

Here’s the key risk facing the Palo Alto Networks stock today

Palo Alto Networks stock continues its strong uptrend this week and is now hovering at its all-time high. PANW jumped by 156% from its lowest point this year, with analysts expecting more gains.  BNP Paribas predicts that PANW will jump from the current $357 to $380, while Wells Fargo sees it soaring to $420. Other

Read More
Bitcoin

Crinetics stocks surge after Vertex agrees to $10B cash buyout

Crinetics Pharmaceuticals shares surged after Vertex Pharmaceuticals announced an agreement to acquire the endocrinology-focused biotech companyin a deal valued at approximately $10 billion. The all-cash transaction values Crinetics at $85 per share and is expected to close during the current quarter, subject to customary conditions. The acquisition sparked a sharp rally in CRNX stock. CRNX

Read More